Sign In
Buy CDTX
$221.38
+0 (+0%)
At Close: Apr 07, 2026
Cidara to Present at the 25th Annual H.C. Wainwright Global Investment Conference
04:05pm, Wednesday, 06'th Sep 2023
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunoth
Cidara shares surge 18.5% as J&J unit Janssen takes lead on flu drug
09:36am, Wednesday, 06'th Sep 2023
Shares of Cidara Therapeutics soared 18.5% in early New York trading, buoyed by news that Janssen Pharmaceuticals, a subsidiary of healthcare giant Johnson & Johnson (NYSE:JNJ) Inc, is set to champion
Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now
10:17pm, Monday, 28'th Aug 2023
As a rule of thumb, you should stay away from penny stocks. When you see shares priced near a buck (or even below), there's usually a reason for it – and not a good one.
Cidara Therapeutics: Leveraging Antifungals To Move Into Cancer Therapy
05:50pm, Thursday, 10'th Aug 2023
Cidara Therapeutics is a biotech company with an approved antifungal drug, Rezzayo, but its sales are not enough to offset expenses. The company's pipeline includes antifungal and antiviral agents, wi
Cidara Therapeutics (CDTX) Reports Q2 Loss, Lags Revenue Estimates
06:46pm, Thursday, 03'rd Aug 2023
Cidara Therapeutics (CDTX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.19 per share a year ago.
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for pat
Cidara Therapeutics to Present at Adenosine Pathway Targeted Cancer Immunotherapy Summit
08:00am, Tuesday, 13'th Jun 2023
SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for pat
Buy Cidara Therapeutics For Data Readout And European Foothold
04:41am, Sunday, 21'st May 2023
With their first product approval last quarter, Europe should follow suit. Their U.S. partner is experienced in commercializing antibiotics.
Top Penny Stocks To Buy Now? 10 To Watch Under $5
11:27am, Thursday, 13'th Apr 2023
10 Penny stocks under $5 to watch right now The post Top Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Cidara Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Friday, 31'st Mar 2023
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patient
7 Top Penny Stocks Under $5; Time To Buy Now?
11:28am, Wednesday, 29'th Mar 2023
Penny stocks to watch before next week. The post 7 Top Penny Stocks Under $5; Time To Buy Now?
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
05:03pm, Friday, 24'th Mar 2023 Benzinga
Gainers
Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Silvergate Capital Corporation (NYSE: SI) climbed 48% to $1.67 on rumor suggesting a crypto exchange is trying to buy Sil
Dow Up 150 Points; Gold Jumps Over 2%
06:32pm, Thursday, 23'rd Mar 2023 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday.
The Dow traded up 0.47% to 32,180.26 while the NASDAQ rose 1.29% to 11,820.77. The S&P 50
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
05:11pm, Thursday, 23'rd Mar 2023 Benzinga
Gainers
DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Boxed, Inc. (NYSE: BOXD) gained 5
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
04:13pm, Thursday, 23'rd Mar 2023 Benzinga
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 450 points on Thursday.
The Dow traded up 1.42% to 32,484.03 while the NASDAQ rose 2.40% to 11,949.60. The S&P 500,
